Identified the novel resistant biomarkers for taxane-based therapy for triple-negative breast cancer

Developing treatment strategies for triple-negative breast cancer (TNBC) has become an important clinical challenge. Currently, taxane-based chemotherapy is one of the standard treatments for TNBC. However, determining the key factor of taxane-resistance is urgently in need for clinical treatment fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chou, Ching-Wen, Huang, Yu-Min, Chang, Yu-Jia, Huang, Chien-Yu, Hung, Chin-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176163/
https://www.ncbi.nlm.nih.gov/pubmed/34104083
http://dx.doi.org/10.7150/ijms.59177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176163/
https://www.ncbi.nlm.nih.gov/pubmed/34104083
http://dx.doi.org/10.7150/ijms.59177

Ejemplares similares